R econstruction of criticalsize bone defects remains a major challenge in orthopedics. 1, 2 Currently, autografting is the gold standard, but the availability of autografts is limited and the procedure involves donor-site morbidity and additional surgery. Allografting is not limited by graft availability but involves the risks of immunological rejection, donor-site pain, and disease transmission. [3] [4] [5] Therefore, bone tissue engineering has emerged as a new technique for the repair of critical-size bone defects. In this technique, [6] [7] [8] seed cells are amplified in vitro and combined with a scaffold with a shape designed to form a construct, which is then grown into a functional bone graft that can be accepted by the host without immunologic rejection. This technique overcomes the intrinsic disadvantages of autografts and allografts.
The availability of seed cells is currently a major concern in bone tissue engineering. Bone marrow mesenchymal stem cells (MSCs) have been used in most studies 9, 10 but have disadvantages: the stem cell concentration is low, only a limited volume of bone marrow can be extracted, and an associated risk exists of harm to the patient during harvesting. Therefore, the overall success of bone marrow MSCs has been limited.
Mesenchymal stem cells derived from other sources, [11] [12] [13] such as embryos and adipose tissues, were also unsuccessfully evaluated as candidate seed cells for bone tissue engineering. 14 Mesenchymal stem cells derived from bone marrow and adipose tissues were found to undergo spontaneous malignant transformation during long-term in vitro culture (4 months or more, amplification 330 or more). 15, 16 Embryoderived mesenchymal stem cells are ethically controversial, difficult to culture in vitro, and can undergo malignant karyotypic and genomic changes during culture. 17, 18 Recently, mesenchymal stem cells have been isolated from fetal appendages, such as the placenta, 19 umbilical cord, 20 and umbilical blood. 21 These cells have been extensively used in clinical studies because of their wide availability, the absence of ethical concerns, and low oncogenicity and bacterial/viral contamination. Placenta-derived mesenchymal stem cells (PDMSCs) have gained particular attention because of their unique biological characteristics. [22] [23] [24] The placenta acts as an immunological barrier between the fetus and the maternal immune system, and the PDMSCs are expected Mesenchymal stem cells (MSCs) have been isolated from a variety of human tissues (eg, bone marrow, peripheral blood, muscle, fat, umbilical blood, amniotic fluid, embryonic tissues, and placenta). Placenta-derived MSCs (PDMSCs) have received considerable interest because of their wide availability and absence of ethical concerns. The authors characterized the biological properties, ultrastructure, growth factor production, and osteoblastic differentiation of PDMSCs and investigated their potential as seed cells for bone tissue engineering.
n the cutting edge to exhibit minimal to no immunogenicity. 25, 26 In addition, because the placenta synthesizes various hormones, enzymes, neurotransmitters, and cytokines, [27] [28] [29] PDMSCs may secrete active factors that facilitate the repair of bone defects.
The 
Materials and Methods
Four placentas were obtained from patients who delivered healthy, full-term infants by cesarean section at the Department of Obstetrics and Gynecology of the Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China between February 22, 2010, and March 2, 2010. All patients were healthy, had no history of infectious diseases or pregnancy complications, and were confirmed to be negative for hepatitis B virus, human immunodeficiency virus, and syphilis. This study was conducted with informed consent from patients and was approved by the hospital's ethics committee.
Primary Culture
Tissues were collected from the maternal aspect of the placenta under sterile conditions and rinsed with phosphate-buffered saline to remove any remaining blood. The tissues were cut into fragments (approximately 1 mm 3 ) and digested with a type-II collagenase solution (37°C water bath for 30 minutes). The resulting fluid was collected and centrifuged at 1500 rotations per minute for 10 minutes. The precipitated cells were collected, resuspended with Dulbecco's Modified Eagle's Medium low glucose (DMEM-LG), transferred into a centrifugation tube containing Ficoll-Hypaque solution, and centrifuged at 2000 rpm for 15 minutes. The white layer was aspirated, rinsed twice with phosphate-buffered saline, and centrifuged to separate the PDMSCs. The cells were plated in DMEM Nutrient Mixture F-12 (DMEM-F12) medium containing 10% fetal bovine serum and incubated in an atmosphere of 5% CO 2 at 37°C with saturated humidity for 7 days. The medium was refreshed, and the nonadherent cells were discarded. The cells were incubated in the same conditions and the medium was refreshed every 3 to 4 days. Cell growth and morphology were observed daily under an inverted microscope. The cells were trypsinized and passaged after reaching a confluence of 80% to 90%.
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Analyses of Immunophenotypes
After reaching an 80% to 90% confluency, the secondpassage cells were rinsed twice with phosphate-buffered saline and trypsinized (.25%) for 1 to 2 minutes. During trypsinization, cells were examined under an inverted optical microscope. If cells presented cytoplasm contraction and intercellular space widening, serum-containing medium was immediately added to the culture to end trypsinization. Then, the fluid was collected and centrifuged (1000 rpm for 8 minutes). After discarding the supernatant, the precipitate was resuspended in phosphate-buffered saline. Monoclonal antibodies that recognize CD29, CD44, CD73, CD105, CD90, CD14, CD34, CD45, CD106, CD133, or human leukocyte antigen (HLA)-DR (5 µL) were each added into a suspension. Mouse immunoglobulin G1 (IgG1) (5 µL) was also added into a suspension and used as the negative control. All of the resulting suspension samples were incubated at 4°C for 30 minutes and then analyzed by flow cytometry (FACSCalibur; BD Biosciences, San Jose, California).
Analyses of Cell Cycle Distributions
Appropriate volumes of the single-cell suspensions were dispensed into tubes (1310 6 cells per tube) and centrifuged. The supernatants were discarded, and the precipitated cells were fixed with ice-cold (220°C) 75% ethanol. The fixed cells were resuspended and centrifuged. The cell pellet was treated with ribonuclease (RNase) to remove RNA, followed by staining with propidium iodide in the dark (4°C for 30 minutes). The cell cycle distributions were then analyzed by flow cytometry.
Analysis of Cellular Apoptosis
Second-passage PDMSCs were rinsed twice with 4°C phosphate-buffered saline and 
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n the cutting edge resuspended in a binding buffer; the cell concentration was adjusted to 1310 6 cells/mL. A small volume (100 µL) of this cell suspension was dispensed into a 5-mL fluorescenceactivated cell sorting tube, and 5 µL of fluorescein isothiocyanate (Annexin V/FITC; Pharmingen, San Diego, California) and 10 µL of propidium iodide (20 µg/ mL) were also added to the tube. The resulting cell suspension was thoroughly mixed and incubated at room temperature in the dark for 15 minutes. Then, 400 µL of phosphate-buffered saline was added to the tube, and the levels of cellular apoptosis were analyzed by flow cytometry.
Analysis of Proliferation Ability
One thousand cells were plated in a 96-well culture dish. In the following 7 days, Cell Counting Kit-8 (Beyotime Institute of Biotechnology, Haimen, China) was added into 5 wells (10 µL/well) and incubated for 1 hour in a CO 2 incubator. The absorbance at 450 nm was measured with a microplate reader.
Ultrastructural Characterization
After reaching confluency, the second-passage cells were rinsed and gently scraped off the culture plates. The cell suspension was centrifuged (1000 rpm for 10 minutes) and rinsed twice with phosphate-buffered saline. The suspension was carefully aspirated off. The cell precipitate was carefully treated with fixant (2% paraformaldehyde12.5% glutaraldehyde) for 30 minutes, rinsed twice with phosphate-buffered saline, fixed with osmium for 1 hour, and rinsed 3 times with phosphate-buffered saline. A small amount of fixed-cell precipitate was collected and then hydrated, embedded, sectioned, and stained by standard procedures. The stained slices were studied with a Philips CM-10 transmission electron microscope (Amsterdam, The Netherlands) for ultrastructures.
Induction of Osteoblastic Differentiation
When the second-passage cells were grown to a confluence of 70% to 80%, the culture fluid was removed by aspiration and replaced with osteogenic differentiation medium (2 mL/ well). The cells were cultured in osteogenic differentiation medium for 16 days with a change of medium every 3 days. The cells were then stained with alizarin red solution (Amresco, Solon, Ohio) using the following procedure. The culture medium was discarded, and the cells were gently rinsed with phosphate-buffered saline and fixed with 10% neutral formaldehyde for 30 minutes. Alizarin red solution was dispensed into the culture plate (1 mL/well) to stain the cells. After staining for 5 minutes, the alizarin red solution was aspirated off. The cells were rinsed with phosphatebuffered saline and examined using standard light microscopy.
Detection of Growth Factor Secretion
Second-passage PDMSCs were cultured in flasks (5310 5 cells/flask) and grown to confluence. Then, the cells were n the cutting edge further cultured in a complete culture medium (DMEM supplemented with 10% serum) for 24 hours, and the culture medium was collected and centrifuged. The supernatant was analyzed by enzyme-linked immunosorbent assay (ELISA) with antibodies to detect VEGF, IGF-1, or HGF, with blank culture media serving as the negative control.
Animal Model of Immunogenicity
Cell Labeling. Secondpassage PDMSCs were labeled with PKH26 (Sigma-Aldrich Co LLC, St Louis, Missouri) according to the manufacturer's instructions. Briefly, a total of 2310 7 human Wharton's jelly cells (passage 2) were washed and resuspended in serum-free DMEM. Following centrifugation at 400 xg for 5 minutes, the supernatant was discarded. The cells were gently resuspended and completely dissolved in 1 mL of Solution C (dilutant for PKH26) (Sigma-Aldrich Co, St Louis, Missouri). The cells were immediately combined with 2310
26 M PKH26 staining reagent (diluted in Solution C). The mixture was incubated at 25°C for 2 to 5 minutes, with gentle rocking of the tube. The staining activity was inhibited by the addition of the same volume of serum for 1 minute. The cells were then centrifuged at 400 xg for 10 minutes at 25°C. The supernatant was removed, and cells were transferred to a new tube. Following 3 washes, 10 mL of complete culture medium was applied, and the cells were centrifuged. The cells were then adjusted to an appropriate density and observed under a fluorescence microscope.
In Vivo Immunogenicity. The immunogenicity of the PDMSCs was evaluated using an animal model. Twenty female inbred Wistar rats (mass, 180-200 g) were divided into 2 groups (10 rats per group). Group 1 rats underwent no treatment and served as the control. Group 2 rats received an injection of PKH26-labeled PDMSCs (1 mL310 6 cells/mL) via the caudal vein. All rats were euthanized 2 months later, and tissues were collected from their organs (ie, brain, liver, kidney, ovary, and uterus), freeze-sectioned into slices, and observed using fluorescence microscopy to study the distribution of PKH26-labeled PDMSCs. Tissue samples were n the cutting edge also stained with hematoxylineosin and examined using light microscopy to evaluate pathological changes and the immune rejection of the PKH26-labeled cells in the hosts.
results
In Vitro Growth
The isolated placental cells exhibited an elongated spindle (fibroblast-like) morphology, abundant cytoplasm, and large nuclei (Figure 1 ). The cells readily attached to the walls of the culture dishes, grew in parallel or vortex-like patterns, and then proliferated rapidly to confluence after 3 to 4 days in culture. The cells were stably passaged.
Expression of Cell Surface Markers
Flow cytometry revealed that the isolated placental cells expressed CD29, CD44, CD73, CD90, and CD105 but not CD14, CD34 (hematopoietic stem cell antigen), CD45 (leukocyte common antigen), CD 106, CD 133, or HLA-DR (major histocompatibility complex II) (Figure 2 ). These findings indicate that the cells only expressed mesenchymal-specific antigens, not hematopoietic-or endothelial-specific antigens, confirming that the isolated cells were human PDMSCs.
Cell Cycle Composition
Flow cytometry revealed that the cell cycle exhibited the following distribution: gap 0/ gap 1, 89.8%61.3%; synthesis, 7.1%61.3%; and gap 2/ mitosis (G2/M), 3.1%61.5% (Figure 3 ). This cell cycle distribution pattern indicated that 10% of the cells, corresponding to the percentage of cells in the gap 2/mitosis or synthesis phase, were proliferating.
Cell Apoptosis
Flow cytometry revealed that 74.2%61.1% of the second-passage PDMSCs were normal, 5.3%6.4% were early apoptotic, 17.2%6.5% were late apoptotic, and the remaining 3.2%6.7% (all n55) were dead ( Figure 4 ).
Cell Proliferation
The rate of PDMSC proliferation was analyzed using the Cell Counting Kit-8 in media containing 10% fetal bovine serum but no growth factors. The rate of cell proliferation was slow during the first 2 days (latent phase), accelerated during days 3 to 6 (logarithmic phase), and slowed thereafter (stationary phase) ( Figure 5 ). During the logarithmic phase, the cells proliferated with a doubling time of 2.9566.204 days.
Ultrastructure
Transmission electron microscopy analysis revealed that the cells had intact membranes and scattered microvilli-like structures on their surfaces (Figure 6 ), which may be related to the inherent capability of the placenta to adhere to the uterus. The intracellular connections comprised primarily tight junctions, with gap junctions observed in some locations, suggesting the presence of intracellular adherence and communication. Most cells contained 1 nucleus, and a few cells contained 2 nuclei. The nuclei contained abundant nucleoplasm and clear inner and outer nuclear membranes. Ribosomes were attached to the external surfaces of the outer nuclear membranes. The nuclei contained single or multiple nucleoli, in which nucleolonema were woven into spongy globules.
Most of the chromatin existed as euchromatin, appearing as areas of low electron density, and a small amount of heterochromatin was observed around the nuclei. Nucleolar margination was 
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n the cutting edge present in some cells, which may facilitate the release of RNA synthesized in the nucleoli into the cytoplasm. The margination indicated that the cells were undergoing active metabolism. Rough endoplasmic reticulum membranes containing abundant ribosomes were scattered throughout the cytoplasm, suggesting active synthesis of proteins required for cell proliferation and a low degree of differentiation. The mitochondria contained tubular cristae, similar to the ultrastructure of endocrine cells.
Induction of Osteoblastic Differentiation
No obvious changes were observed immediately after the cells were transferred to osteogenic differentiation medium. After culture for 6 days in osteogenic differentiation medium (2 changes of osteogenic differentiation medium), the cell viability decreased, and the cells transformed from their original fibroblast-like morphology to having a flat or polygonal appearance; the cells also showed a reduced gloss. After culture for 12 days in osteogenic differentiation medium (4 changes of osteogenic differentiation medium), the cells became flat, and a small number of mineralized nodules were observed. After culture for 15 days (5 changes of osteogenic differentiation medium), the number of mineralized nodules increased.
After culture for 16 days, the cells changed from a spindlelike morphology to a cubic morphology, and the density of mineralized nodules became relatively stable, suggesting they had reached a relatively stable differentiated state. The mineralized nodules were stained a dark red color by alizarin red ( Figure  7) , indicating that the human PDMSCs had differentiated toward an osteoblast lineage.
Secretion of Growth Factors
Vascular endothelial growth factor (12.46.7 ng/mL), IGF-1 (86.96.8 pg/mL), and HGF (190.163.5 pg/mL) were detected in the medium from cultured PDMSCs, indicating that they were secreted. In contrast, none of these factors were detected in the control sample (ie, cell-free osteogenic differentiation medium).
In Vivo Immunogenicity
PKH26 Cell Labeling. PKH26-labeled cells emitted red fluorescence under the fluorescence microscope ( Figure  8 ). The PKH26 dye appeared uniformly distributed on the cell membranes. Trypan blue staining showed that the cells had a survival rate of more than 99%.
Animal Response. The 2 groups appeared similar in activity, food intake, urination, and defecation. None of the rats developed symptoms associated with organ embolism (eg, drowsiness, vomiting, convulsion, anuria, mental abnormality, hemiplegia, or sudden death) or acute or chronic immune rejection (eg, dyspnea, bleeding, hair loss, hematuria, or hematochezia).
Distribution of Transplanted PDMSCs in Hosts.
Fluorescence microscopy revealed that PKH26-labeled PDMSCs were distributed in various organs of the host rats, including the lungs, livers, kidney cortices, ovaries, and uteri. However, no PDMSCs were detected in their brains ( Figure 9 ). The cells were distributed homogeneously in the lungs but with local aggregation. They were also distributed uniformly in the livers and clearly revealed their structures, including the bile ducts and major blood vessels. The cells were present in the kidneys (mainly in the cortices) and clearly delineated the profiles of the renal corpuscles. They were distrib- 
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n the cutting edge uted in the ovaries and primarily in the ovarian stroma; however, no red fluorescence was detected in the ovarian follicles. The cells were also observed in the uteri, mostly in their myometria, followed by their endometria. Pathological Examinations. Light microscopy revealed that all tissues examined, including ovary, uterus, liver, kidney, and brain, had no signs of obvious lymphocyte infiltration or structural damage. The 2 groups appeared generally similar (Figure 10 ).
discussion
This study found that PDMSCs isolated from human placenta can be induced to differentiate into osteoblasts and are capable of producing mineralized extracellular matrix. This finding may have valuable implications for the tissue engineering of bone grafts.
The successful culture of seed cells is a critical factor in bone tissue engineering. Ideally, seed cells should be able to actively proliferate in vitro, readily differentiate into osteoblasts, retain osteogenic activity following implantation into the host bone, and not induce severe immunological rejection by the host. In addition, they should produce bioactive factors to facilitate integration of the graft with the host bone, and they should be easily harvested with minimal damage to the body. To date, several types of cells have been used for bone tissue engineering, including chondrocytes, embryonic stem cells, bone marrow MSCs, adipose-derived stem cells, and osteoblasts isolated from the periosteum or trabecular bone. These candidate seed cells have advantages and inherent disadvantages. For example, although bone marrow MSCs are multipotent, they are associated with oncogenicity and viral and bacterial contamination, and their extraction is associated with other types of damage. 32, 33 Embryonic stem cells can be induced to differentiate into osteoblasts, 34 but they are 
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n the cutting edge difficult to culture and involve substantial ethical concerns. Furthermore, adipose-derived stem cells might undergo malignant transformation during in vitro culture. 35 Therefore, the current authors investigated the potential of PDMSCs as seed cells for bone tissue engineering because of 2 unique factors: (1) the immunological isolation between the fetus and the maternal environment during pregnancy and (2) the secretion of bioactive factors required to sustain pregnancy.
In vitro cultured PDMSCs exhibited important properties that met the requirements of seed cells for bone tissue engineering. During passaging, the PDMSCs could grow readily and doubled in number in every 2 to 3 days, indicating they were actively proliferating and exhibited strong self-renewal. Transmission electron microscopy studies confirmed that the PDMSCs were undergoing active metabolism and had a low degree of differentiation. Moreover, transmission electron microscopy revealed tubular cristae in their mitochondria, which is similar to the ultrastructure of mitochondria in endocrine cells, suggesting a structural basis for their secretion of bioactive factors. Furthermore, ELISA indicated that the PDMSCs secreted VEGF, IGF-1, and HGF, which are known to play fundamental roles in bone healing and bone tissue engineering. Vascular endothelial growth factor is the most potent angiogenic factor yet identified, and it plays critical roles in angiogenesis and bone fracture healing. 36 Hepatocyte growth factor is an important factor that modulates the activity of osteoblasts. 37, 38 Insulin-like growth factor 1 can stimulate the differentiation and proliferation of bone cells and thus plays important roles in the repair of bone defects and in bone tissue engineering. 39 Placenta-derived mesenchymal stem cells cultured in osteogenic differentiation medium differentiated into osteoblasts and produced mineralized extracellular matrix. In addition to these positive findings, PDMSCs may have other favorable properties for bone tissue engineering. They exist in larger numbers in the human body than bone marrow stromal stem cells or adipose-derived stromal stem cells, and they can be obtained with relative ease and without damage to the donor, in contrast to the collection of bone marrow MSCs. These cells also present lower risks of carcinogenicity and viral and bacterial contamination than bone marrow MSCs. They involve no ethical concerns, and they can be cultured substantially more easily than embryonic stem cells.
Placenta-derived mesenchymal stem cells may also exhibit the inherently low immunogenicity of the placenta, which may in turn minimize the potential for host rejection. This was corroborated by the animal transplantation model. In this study, adult female rats with mature immune systems were selected as the hosts because younger or older animals may more easily develop tolerance to foreign cells and thus introduce bias. The host rats received no immunosuppressant or other treatments to attenuate their immune reactions, thus allowing for the reliable observation of the immune response to the transplanted PDMSCs. An intravenous injection model was used to evaluate the immunnogenicity of the PDMSCs due to the important roles of the blood circulation system in immune reactions. In addition to specialized immune cells (eg, T-cells, natural killer [NK] cells, and granulocytes), other blood cells, such as erythrocytes [40] [41] [42] and platelets, 43, 44 also express immune-related molecules (eg, CD35, CD55, CD58, CD59, and chemokine receptors) and are involved in n the cutting edge the modulation of T-cell immune functions. These findings suggest that immunogens will elicit systemic immune responses after entering the blood circulation. Moreover, the dynamic development of innate and adaptive immunity in the blood can provide key insights into the systemic immune response in the host. Therefore, the current intravenous injection model was expected to provide through and reliable information regarding the immunogenicity of PDMSCs in rats.
Following injection via the caudal vein, the cells migrated within the blood stream to various organs (eg, lung, liver, kidney, ovary, and uterus) and survived. They were identified by their red fluorescence 2 months after transplantation, suggesting that they survived and were not attacked by the host immune system. Pathological examinations of tissues from various organs showed no signs of lymphocyte infiltration or structural damage, suggesting that the organs retained their normal structures. Macroscopically, all of the rats appeared normal after transplantation with no symptoms of acute or chronic immune rejection. These results showed that human PDMSCs could be tolerated following transplantation into a different species and that both the transplanted cells and the host can survive long-term with no immunosuppressive treatment. This finding suggests that PDMSCs have low or no immunogenicity, probably because they do not express surface markers related to the immune response (eg, HLA-DR) (Figure 2 ) and the host cannot recognize them as foreign cells. Furthermore, no PKH26-labeled cells were identified in the host brains, suggesting that PDMSCs cannot penetrate the bloodbrain barrier. More recently, a study was performed in which PDMSCs were transplanted into rat ovaries, and the results were similar to those of the current study for the intravenous injection experiments (Z.-N.Z., unpublished data).
conclusion
The results of this study suggest that PDMSCs offer advantages in availability, biological activities, cell adhesion, immunogenecity, cytokine production, and osteoblastic differentiation. The combination of these favorable properties may make PDMSCs a promising seed cell candidate for bone tissue engineering.
